PTAB grants rehearing of Genentech patent IPR

31-10-2017

PTAB grants rehearing of Genentech patent IPR

bee32 / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer.


Patent Trial and Appeal Board, PTAB, inter partes review, IPR, Genentech, Hospira, Pfizer, trastuzumab, Herceptin

LSIPR